Project Altair Holdco Limited

#12920804 • Active

tranScrip is a specialist pharmaceutical consultancy that provides strategic expertise and operational excellence across the entire product lifecycle, from translation to prescription, ensuring optimal outcomes for patients worldwide.

Founded: 1 Oct 2020
Industries:
74990 - Non-trading company
Website: transcrip-group.com
Phone: +44(0)2036271104
Email: dpo@transcrip-group.com
Location: Birmingham

Products & Services

• clinical development
• clinical trials
• commercialisation
• early development
• medical affairs
• pharmaceutical consultancy
• pharmacovigilance & risk management
• regulatory affairs

Financial Snapshot

Last accounts made up to 31 Mar 2024
Next accounts due 31 Mar 2026 (3 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →
See Full Financials →

People

Officers
6
Shareholders
38
Controllers (PSC)
4
Gareth Alan Dyson
Director • British • Lives in England • Born in Dec 1980
Mark Edward Corbett
Director • British • Lives in England • Born in Jul 1972
Matthew John Coles
Director • British • Lives in England • Born in Dec 1987
Paul Mccluskey
Director • British • Lives in England • Born in Dec 1963
Linda Summerton
Director • British • Lives in England • Born in Aug 1962
See Key People →

Registered Office Address

111 Edmund Street

Birmingham

B3 2HJ

United Kingdom

View on Map →

Basic Information

LTD
1 Oct 2020
ENGLAND WALES
Yes

Industry Classification

74990

Company Attributes

N/A
N/A
N/A
N/A

Summary

14
Officers
4
PSCs
0
Filings